BioFluidica
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11575 Sorrento Valley Rd Ste 210, San Di...Phone Number
(858) 535-6493Website
www.biofluidica.comRevenue
<$5 MillionIndustry
About BioFluidica
BioFluidica is a privately held biotechnology company that has developed a revolutionary platform enabling disease management and diagnosis through prognosis, all from a simple blood test. The BioFluidica microfluidic platform can capture and isolate disease biomarkers, such as Circulating Tumor Cells (CTC), and has been clinically validated. Its ability to scan whole blood for the first signs of a disease, finding the rarest biomarkers with unmatched sensitivity, means fulfilling the promise of a true liquid biopsy. BioFluidica is revolutionizing disease detection by bringing better samples to millions of people.Explore more
BioFluidica Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to BioFluidica
Compare insights from companies similar to BioFluidica, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
BioFluidica Tech Stack
A closer look at the technologies used by BioFluidica
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioFluidica
Sign Up For FreeTo access detailed company insights
BioFluidica is a privately held biotechnology company that has developed a revolutionary platform enabling disease management and diagnosis through prognosis, all from a simple blood test. The BioFluidica microfluidic platform can capture and isolate disease biomarkers, such as Circulating Tumor Cells (CTC), and has been clinically validated. Its a... Read More
